ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Nanosphere, Inc." (NSPH) Report Updated: Apr 21, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"Nanosphere, Inc." (NSPH)

Rating: Sell Volatility: Aggressive
Total Grade: D Industry: Biotechnology
Competitors: CPRX, INSY, RGEN, CRMD

Stock Analysis

Rating: Monthly View

A
B
C
D
F
April May June July August September October November December January February March

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up downgrade
service keys

"Nanosphere, Inc."© quotemedia

Company Profile

Nanosphere, Inc. develops, manufactures, and markets molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Its Verigene System includes a bench-top molecular diagnostics workstation with nanoparticle technology that provides the ability to run multiple tests simultaneously on the same sample. The Verigene System is used for testing infectious disease assays, human and pharmacogenetic assays, and ultra-sensitive protein assays. The company serves hospital-based laboratories and academic research institutions in the United States. Nanosphere, Inc. was founded in 1998 and is headquartered in Northbrook, Illinois.

Recent News: "Nanosphere, Inc."